 UPPSALA, Sweden, Jan. 27, 2021 PRNewswire -- Orexo AB publ., STO: ORX OTCQX: ORXOY today announces that the company has further strengthened the intellectual property IP for its flagship pharmaceutical pipeline asset OX124, a naloxone rescue medication for the treatment of... 